Platinum as both a drug and its modulator – Do platinum nanoparticles influence cisplatin activity?
- 30 December 2024
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 407, 111365
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Bimetallic gold-platinum nanoparticles as a drug delivery system coated with a new drug to target glioblastomaColloids and Surfaces B: Biointerfaces, 2022
- Usage of Platinum Nanoparticles for Anticancer Therapy over Last Decade: A ReviewParticle & Particle Systems Characterization, 2021
- Doxorubicin/cisplatin co-loaded hyaluronic acid/chitosan-based nanoparticles for in vitro synergistic combination chemotherapy of breast cancerCarbohydrate Polymers, 2019
- Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell linesBiomedicine & Pharmacotherapy, 2019
- Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell lineColloids and Surfaces B: Biointerfaces, 2018
- Targeted iron nanoparticles with platinum-(IV) prodrugs and anti-EZH2 siRNA show great synergy in combating drug resistance in vitro and in vivoBiomaterials, 2018
- Improved cisplatin delivery in cervical cancer cells by utilizing folate-grafted non-aggregated gelatin nanoparticlesBiomedicine & Pharmacotherapy, 2015
- Magnetically controlled release of cisplatin from superparamagnetic starch nanoparticlesCarbohydrate Polymers, 2012
- Caffeine, pentoxifylline and theophylline form stacking complexes with IQ-type heterocyclic aromatic aminesBioorganic Chemistry, 2011
- Size‐Dependent Cytotoxicity of Gold NanoparticlesSmall, 2007